Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 100,000 shares at $104.89 ($10.5M) on 2025-09-02, disclosed to the SEC on 2025-09-03.
Scheduled sale ($10.5M) by EVP & Group President, Cardiology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.89 | 21,830 | $2.3M | 21.7% |
| 2 | $104.89 | 21,830 | $2.3M | 21.7% |
| 3 | $105.85 | 28,170 | $3.0M | 28.3% |
| 4 | $105.85 | 28,170 | $3.0M | 28.3% |
| Total | $105.43 avg | 100,000 | $10.5M | 100% |
| Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |
| BSX | SELL | 2025-06-04 | $11.6M | — | Filing → |